Arthur Fratamico Panbela Therapeutics, Inc. (PBLA) insider trading activity

PBLA Quotes by TradingView

Arthur Fratamico is Director of Panbela Therapeutics, Inc.. Currently has a direct ownership of 9,615 shares of PBLA, which is worth approximately $3,172. The most recent transaction as insider was on May 25, 2021, when has been sold 4,316 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.62K
0% 3M change
0% 12M change
Total Value Held $3,172

Arthur Fratamico Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 25 2021
BUY
Grant, award, or other acquisition
-
4,316 Added 30.98%
9,615 Common Stock
Dec 01 2020
BUY
Grant, award, or other acquisition
-
2,875 Added 35.17%
5,299 Common Stock

Also insider at

GRTX
Galera Therapeutics, Inc. Healthcare
Chief Business Officer
AF

Arthur Fratamico

Director
Waconia, MN

Track Institutional and Insider Activities on PBLA

Follow Panbela Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PBLA shares.

Notify only if

Insider Trading

Get notified when an Panbela Therapeutics, Inc. insider buys or sells PBLA shares.

Notify only if

News

Receive news related to Panbela Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PBLA